Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Seegene: Unlocking the potential of molecular diagnostics
Seegene is a global molecular diagnostics company providing a total real-time PCR solution for healthcare through their unique, patented technology that combines high multiplex diagnostic assays with automatic testing systems.
The vision of Seegene is to take a step closer to a world free from all diseases and future pandemics through early syndromic PCR diagnosis in all fields.
This collection of articles describe Seegene’s advances in syndromic PCR development and applications.
A company in South Korea has embarked on a bold plan to consolidate the world’s PCR library resources into a single formidable system — and then collaborate with global experts to make syndromic PCR assays more accessible.
The ability to check for many pathogens simply and simultaneously will make PCR tests more powerful than ever before, says a South Korean Company which is pursuing “molecular diagnostics for a world free from all disease”.
Polymerase chain reaction (PCR) testing, which played such a key role in tackling the COVID-19 pandemic, could be a critical technology for addressing future threats to human health.